Search Tag: DIGIT-HF

2025 31 Aug

Digitoxin reduced the risk of a composite endpoint of all-cause death and hospitalisation for worsening heart failure (HF) in patients with advanced HF and reduced ejection fraction (HFrEF), according to late-breaking results from the DIGIT-HF trial presented in a Hot Line session at ESC Congress 2025.   Cardiac glycosides such as digitoxin and...Read more